Rod Raynovich

AMAG Pharmaceuticals Worth Far Less - Merrill

AMAG had a bullet proof business model but it was based upon milestone assumptions one year later.In the meantime the entire former management team bailed at the top~$65/sh. Now the FDA and launch milestone dates are here and the Co. cant deliver. See Yahoo chat on competitition.In the meantime hedgies who moved the stock up from 30 to 70 are getting out.